eli lilly news glp-1 Retatrutide, the next generation of drug from Lilly, helped participants lose an average of 71.2 pounds and reduce knee arthritis pain in a late-stage clinical trial, the company announced. In Lilly's new GLP-1 pill is
Description
Learn how its antioxidants support metabolic health and help manage appetite for weight loss.
Thirteen state Medicaid programs are covering GLP-1 drugs for the treatment of obesity this year, down from 16 last year.
GLP-1 users are spending less on indulgent snacks like chips and cookies, while buying more yogurt, fruit, and vegetables
Discover the relationship between Saxenda and bile acid malabsorption
